Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus

References

• Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227–1239
   PubMed Web of Science ®Google Scholar
• Said G. Diabetic neuropathy — A review. Nat Clin Pract Neurol. 2007;3(6):331–340
   PubMedGoogle Scholar
• Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab. 2008;4(8):444–452
   PubMedGoogle Scholar
• Kanwar YS, Wada J, Sun L, et al. Diabetic nephropathy: Mechanisms of renal disease progression. Exp Biol Med. (Maywood) 2008;233(1):4–11
   PubMed Web of Science ®Google Scholar
• Singh DK, Winocour P, Farrington K. Mechanisms of disease: The hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol. 2008;4(4):216–226
   PubMedGoogle Scholar
• Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol. 2010;21(3):438–447
   PubMed Web of Science ®Google Scholar
• Krishan P, Chakkarwarb VA. Diabetic nephropathy: Aggressive involvement of oxidative stress. J Pharm Educ Res. 2011;2(1):35–41
   Google Scholar
• Hudkins KL, Pichaiwong W, Wietecha T, et al. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol. 2010;21(9):1533–1542
   PubMed Web of Science ®Google Scholar
• Palmer ND, Freedman BI. Insights into the genetic architecture of diabetic nephropathy. Curr Diab Rep. 2012;12(4):423–431
   PubMed Web of Science ®Google Scholar
• Al-Kateb H, Boright AP, Mirea L, et al. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes. 2008;57(1):218–228
   PubMedGoogle Scholar
• Maeda S, Araki S, Babazono T, et al. Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes. 2010;59(8):2075–2079
   PubMed Web of Science ®Google Scholar
• Ng DP, Tai BC, Lim XL. Is the presence of retinopathy of practical value in defining cases of diabetic nephropathy in genetic association studies? The experience with the ACE insertion/deletion polymorphism in 53 studies comprising 17,791 subjects. Diabetes. 2008;57(9):2541–2546
   PubMed Web of Science ®Google Scholar
• Lim XL, Nurbaya S, Salim A, et al. KCNQ1 SNPS and susceptibility to diabetic nephropathy in East Asians with type 2 diabetes. Diabetologia. 2012;55(9):2402–2406
   PubMed Web of Science ®Google Scholar
• Mooyaart AL, Valk EJ, van Es LA, et al. Genetic associations in diabetic nephropathy: A meta-analysis. Diabetologia. 2011;54(3):544–553
   PubMed Web of Science ®Google Scholar
• Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol. 2010;299(1):F14–F25
   PubMed Web of Science ®Google Scholar
• Goyette P, Pai A, Milos R, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome. 1998;9(8):652–656
   PubMed Web of Science ®Google Scholar
• Trimmer EE. Methylenetetrahydrofolate reductase: Biochemical characterization and medical significance. Curr Pharm Des. 2013;19(14):2574–2593
   PubMed Web of Science ®Google Scholar
• Clarke R, Collins R, Lewington S, et al. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA. 2002;288(16):2015–2022
   PubMed Web of Science ®Google Scholar
• Bousman CA, Potiriadis M, Everall IP, Gunn JM. Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees. Am J Med Genet B Neuropsychiatr Genet. 2014;165B(1):68–76
   PubMedGoogle Scholar
• Liang H, Yan Y, Li T, et al. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: A meta-analysis of 22 case–control studies. Tumour Biol. 2014;35(2):1695–1701
   PubMed Web of Science ®Google Scholar
• Sahiner UM, Alanay Y, Alehan D, Tuncbilek E, Alikasifoglu M. Methylene tetrahydrofolate reductase polymorphisms and homocysteine level in heart defects. Pediatr Int 2014;56(2):167--172
   PubMed Web of Science ®Google Scholar
• Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 1995;56(1):142–150
   PubMed Web of Science ®Google Scholar
• Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet. 1991;48(3):536–545
   PubMed Web of Science ®Google Scholar
• Zhou TB, Xu HL, Yin SS. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility. Ren Fail. 2013;35(1):173–178
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail. 2013;35(4):573–578
   PubMed Web of Science ®Google Scholar
• Qin YH, Zhou TB, Su LN, Lei FY, Huang WF, Zhao YJ. Association between ACE polymorphism and risk of IgA nephropathy: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011;12(3):215–223
   PubMed Web of Science ®Google Scholar
• Zhou TB, Ou C, Qin YH, et al. Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011;12(4):601–610
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Su LN, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: A systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011;12(4):624–633
   PubMed Web of Science ®Google Scholar
• Zhou TB, Liu YG, Lin N, et al. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/Lupus nephritis: A systematic review and metaanalysis. J Rheumatol. 2012;39(4):686–693
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ. ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: A meta-analysis. PLoS One. 2011;6(5):e19599
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634
   PubMed Web of Science ®Google Scholar
• Bluthner M, Bruntgens A, Schmidt S, Strojek K, Grzeszczak W, Ritz E. Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? Nephrol Dial Transplant. 1999;14(1):56–57
   PubMed Web of Science ®Google Scholar
• Shpichinetsky V, Raz I, Friedlander Y, et al. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr. 2000;130(10):2493–2497
   PubMed Web of Science ®Google Scholar
• Ksiazek P, Bednarek-Skublewska A, Buraczynska M. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit. 2004;10(2):BR47–BR51
   PubMed Web of Science ®Google Scholar
• Mtiraoui N, Ezzidi I, Chaieb M, et al. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2007;75(1):99–106
   PubMed Web of Science ®Google Scholar
• Boger CA, Stubanus M, Haak T, et al. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol Dial Transplant. 2007;22(1):154–162
   PubMed Web of Science ®Google Scholar
• Eroglu Z, Erdogan M, Tetik A, et al. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Metab Res Rev. 2007;23(8):621–624
   PubMed Web of Science ®Google Scholar
• Ukinc K, Ersoz HO, Karahan C, et al. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine. 2009;36(2):255–261
   PubMed Web of Science ®Google Scholar
• Nemr R, Salman RA, Jawad LH, Juma EA, Keleshian SH, Almawi WY. Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs. Clin Chem Lab Med. 2010;48(8):1091–1094
   PubMed Web of Science ®Google Scholar
• Maeda M, Yamamoto I, Fukuda M, et al. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients. J Diabetes Complications. 2008;22(2):119–125
   PubMed Web of Science ®Google Scholar
• Movva S, Alluri RV, Venkatasubramanian S, et al. Association of methylene tetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications. Genet Test Mol Biomarkers. 2011;15(4):257–261
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Yoshida T, Umekawa T, et al. Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients. Diabet Med. 2004;21(9):1051–1052
   PubMed Web of Science ®Google Scholar
• Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant. 2003;18(8):1535–1540
   PubMed Web of Science ®Google Scholar
• Odawara M, Yamashita K. A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy. Diabetologia. 1999;42(5):631–632
   PubMed Web of Science ®Google Scholar
• Neugebauer S, Baba T, Watanabe T. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet. 1998;352(9126):454
   PubMed Web of Science ®Google Scholar
• Fujita H, Narita T, Meguro H, et al. No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy. J Diabetes Complications. 1999;13(5–6):284–287
   PubMed Web of Science ®Google Scholar
• El-Baz R, Settin A, Ismaeel A, et al. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst. 2012;13(4):472–477
   PubMed Web of Science ®Google Scholar
• Sun J, Xu Y, Zhu Y, Lu H. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract. 2004;64(3):185–190
   PubMed Web of Science ®Google Scholar
• Rahimi M, Hasanvand A, Rahimi Z, et al. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Clin Biochem. 2010;43(16–17):1333–1339
   PubMed Web of Science ®Google Scholar
• Qian D. Matched case–control study on the association between AGT and MTHFR gene polymorphism and diabetic nephropathy. Tianjing: Tianjing Medical University Press; 2010: 17 p
   Google Scholar
• Lin R, Wang C, Liu X. Matched case–control study on the association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and diabetic nephropathy in type 2 diabetic patients. Modern Prevent Med. 2009;36(20):3801–3804
   Google Scholar
• Wen J, Chen Z, Li X, et al. Correlation of MTHFR gene polymorphism and plasma homocysteine with microalbuminuria in type 2 diabetes. Shanghai Med J. 2008;31(1):47–51
   Google Scholar
• Yue H, Liu J, Kang W, et al. Relationship between plasma level of homocysteine and urine microalbumin in incipient type 2 diabetic nephropathy. Chin J Gen Pract. 2006;5(12):725–729
   Google Scholar
• Mao L. A correlation between 5,10-methylenetetrahydrofolate reductase gene polymorphism, serum homocysteine levels and vascular complications in patients type 2 diabetic mellitus. Jiangsu: Nantong Medical College Press; 2004: 27 p
   Google Scholar
• Chen A, Ning Y, Zhu X, Li L, Shi H. Study on the relationship between gene polymorphisms of N5,10-methylenetetrahydrofolate reductase and nephropathy in type 2 diabetes mellitus in Gansu Han Chinese of China. Clin J Prev Contr Chron Non-Commun Dis. 2004;12(5):195–197
   Google Scholar
• Xu J, Zhang J, Shan B, Ma H. Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes mellitus in the Hans of Hebei Province. Clin Focus. 2003;18(14):787–789
   Google Scholar
• Guo Q, Lu J, Qin H, Sheng C, Yin S, Pan C. Changes of the plasma homocysteine and its mechanism in type 2 diabetes with microangiopathy. Chin J Diabetes. 2002;10(1):32–36
   Google Scholar
• Yang G, Lu J, Pan C. Study on the relationship between N5,10-methylenetetrahydrofolate reductase gene polymorphism and the susceptibility to microangiopathy in type 2 diabetes mellitus. Chin J Endocrinol Metab. 2001;17(4):224–227
   Google Scholar
• Wang L, Wang J, Xue Y, Cheng Y, Zou H. Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy. Chin J Med Genet. 2001;18(4):226–228
   Google Scholar
• Cao H, Huang D, Mao L, Gao Y. Association of homocysteine, methyleneterahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus. ACTA Universitatis Medicinalis Nanjing (Natural Science). 2005;25(4):249–251
   Google Scholar
• Sun L, Wang S, Shi X, Yang Z. Interactions between APOE and MTHFR mutations is associated with the risk for type 2 diabetic nephropathy. J Med Mol Biol. 2013;10(2):95–99
   Google Scholar
• Dai H, Zhang Y. An association study of MTHFR and eNOS genes polymorphism with diabetic nephropathy. Chin J Trauma Disabil Med 2012;20(6):4–6
   Google Scholar
• Sun L, Wang S, Wang X, Shi X, Yang Z. Association study between MTHFR C677T polymorphism and levels of Scr and BUN in diabetic nephropathy patients. Chinese J Health Lab Technol. 2013;23(5):1167–1169
   Google Scholar
• Sun J, Xu Y, Zhu Y, et al. An association study of methylenetetrahydrofolate reductase gene polymorphism with diabetic nephropathy. J Nephrol Dial Transplant. 2001;10(1):33–35
   Google Scholar
• Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990;33(7):438–443
   PubMed Web of Science ®Google Scholar
• Li J, Shi M, Zhang H, et al. Relation of homocysteine to early nephropathy in patients with Type 2 diabetes. Clin Nephrol. 2012;77(4):305–310
   PubMed Web of Science ®Google Scholar
• Sun J, Xu Y, Zhu Y. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabet Res Clin Pract. 2004;64(5):185–190
   PubMedGoogle Scholar
• James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr. 1999;70(4):495–501
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–113
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: A meta-analysis. J Hum Genet. 2007;52(11):881–890
   PubMed Web of Science ®Google Scholar
• Niu W, Qi Y. An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy. Diabetes Res Clin Pract. 2012;95(1):110–118
   PubMed Web of Science ®Google Scholar
• Chang WW, Zhang L, Yao YS, Su H, Jin YL, Chen Y. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and susceptibility to diabetic nephropathy in Chinese type 2 diabetic patients: A meta-analysis. Ren Fail. 2013;35(7):1038–1043
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang J, Feng C, Huang G. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: A meta-analysis. Metabolism. 2013;62(4):586–594
   PubMed Web of Science ®Google Scholar
• Kidney & Urinary Pathway Knowledge Base. Renal Fibrosis Laboratory (INSERM, France) and the Bio-health Informatics Group (University of Manchester, UK). Available at: www.kupkb.org/
   Google Scholar
• Human Kidney and Urine Proteome Project. Human Proteome Organization (Santa Fe, US). Available at: http://www.hkupp.org/
   Google Scholar
• Nephromine. Applied Systems Biology Core O'Brien Renal Center (University of Michigan, US) and Compendia Bioscience (Life Technologies, US). Available at: www.nephromine.org/
   Google Scholar
• Willnow T, Antignac C, Brandli A, et al. The European renal genome project: An integrated approach towards understanding the genetics of kidney development and disease. Organogenesis. 2005;2(2):42–47
   PubMedGoogle Scholar